• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconModerna

Moderna

Page 5 of 18
HealthModerna says its vaccination with booster ‘almost obliterates’ Omicron in the short term
By Chris MorrisJanuary 27, 2022
COVID-19 hospitalizations
HealthPfizer and Moderna boosters keep you safe from Omicron hospitalization, CDC says
By Fiona Rutherford and BloombergJanuary 21, 2022
HealthModerna chair says COVID could become flu-like endemic in 2022
By James Paton and BloombergJanuary 14, 2022
A man receives a fourth dose of COVID-19 vaccine at Sheba Medical Center in central Israeli city of Ramat Gan on Dec. 31, 2021.
HealthPushback grows against fourth COVID vaccine doses, with experts urging caution over expanding booster campaigns
By David MeyerJanuary 11, 2022
Photo illustration of Omicron Covid-19 and vaccine needle
HealthDoctor says we need to take Omicron more seriously after detailing his son’s symptoms
By Andrew MarquardtJanuary 10, 2022
HealthSingapore ranks COVID vaccines by death rate—and Moderna comes out on top
By Low De Wei and BloombergJanuary 10, 2022
HealthWith Omicron dominant, new COVID cases are up 254%—and those are just the reported ones
By Erika Fry and Nicolas RappJanuary 5, 2022
Photo illustration of a syringe jabbing a stock chart that shows shares rising and then falling
FinanceOmicron is upping booster jab demand. So why are COVID vaccine makers’ shares tanking?
By Jeremy KahnDecember 29, 2021
A health care worker prepares a Moderna booster vaccine dose.
HealthModerna hit by shareholders who want to know why its COVID-19 vaccine is so expensive and unavailable in poorer countries
By David MeyerDecember 27, 2021
HealthEU bulks up its arsenal against Omicron with approval of Novavax vaccine. Investors dump shares
By Christiaan HetznerDecember 20, 2021
HealthModerna says its COVID-19 booster vaccine delivers a massive increase in antibodies
By Suzi Ring, Naomi Kresge and BloombergDecember 20, 2021
HealthJ&J, Sputnik, and Sinopharm vaccines found to be largely ineffective in fighting Omicron: study
By BloombergDecember 17, 2021
HealthCDC panel recommends Pfizer and Moderna vaccines over Johnson & Johnson
By Lauran Neergaard, Mike Stobbe and The Associated PressDecember 16, 2021
HealthA desperate Germany turns to vaccine-hesitant Eastern Europe for COVID jabs
By Christiaan HetznerDecember 16, 2021
HealthAs COVID deaths top 800,000, Omicron and Delta variants threaten another U.S. surge
By Erika Fry and Nicolas RappDecember 15, 2021
1...
  • 3
  • 4
  • 5
  • 6
  • 7
...18
Most Popular
Magazine
The youngest-ever female CEO of a Fortune 500 company is fighting Trump's cuts to keep Medicaid strongAn image of a popular article
By Fortune EditorsMarch 24, 2026
Success
Palantir’s billionaire CEO says only two kinds of people will succeed in the AI era: trade workers — ‘or you’re neurodivergent’An image of a popular article
By Fortune EditorsMarch 24, 2026
Commentary
The Treasury just declared the U.S. insolvent. The media missed itAn image of a popular article
By Fortune EditorsMarch 23, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.